COPD Trial, Recruiting NCT06523140 Sponsor: Biosency Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06523140
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People over 18 years of age who have been diagnosed with COPD (a long-term lung condition) according to established medical guidelines, and whose lung function has been measured within the last 12 months while their condition was stable
  • People who have been admitted to hospital at least once in the past 12 months due to a worsening of their COPD symptoms
  • People who have been fully informed about the trial and have signed a consent form agreeing to take part
  • People who are enrolled in a French social security scheme

Who may not be able to join:

  • People who have another serious or unstable health condition, as assessed by the trial doctor
  • People who have been identified as having significant psychological vulnerabilities
  • People who are already taking part in another clinical trial that involves an intervention
  • People who do not speak French and are unable to use a device called the Bora Band tool, and who do not have a carer available to assist them
  • People who are under legal guardianship or who are otherwise unable to give free and fully informed consent
  • People who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nicolas ROCHE, MD, Hôpital Cochin, AP-HP

Phone: 02 21 65 70 01

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Biosency
Registry
ClinicalTrials.gov
Start date
20 November 2024
Est. completion
1 December 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Demonstrate the superiority of remote monitoring with the Bora Care solution in patients with COPD and frequent exacerbations compared to conventional follow-up.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov